Ameridose Vice President of Regulatory Affairs and Compliance Presents at LSHP Annual Meeting

Westborough, MA, July 26, 2011 --(PR.com)-- Ameridose, LLC, a leading nationwide provider of sterile admixing services to hospital pharmacies, is honored that Ameridose Vice President of Regulatory Affairs and Compliance, Sophia Pasedis, PharmD, was invited to speak at the 2011 Louisiana Society of Health-System Pharmacists (LSHP) Annual Meeting in New Orleans. Dr. Pasedis’ talk, Enhancing Patient Safety through USP <797> Compliance, covered the basics of USP <797> and offered tips on how to achieve continuous compliance improvement in today’s resource constrained environment.

“At Ameridose, I have been involved with USP <797> compliance on a daily basis, so, of course, I was thrilled to receive the request to offer an ACPE program on USP <797> at the LSHP Annual Meeting. I was pleased to find the annual meeting to be very well-attended and the audience fully engaged in the topic of USP <797>. My personal objective was for each attendee to take away something they could implement in their own facility,” stated Sophia Pasedis, PharmD, Vice President of Regulatory Affairs and Compliance for Ameridose, LLC.

About Ameridose, LLC
Ameridose (www.Ameridose.com) is the leading provider of high quality sterile admixed and repackaged preparations and oral repackaging services to hospital pharmacies nationwide. Ameridose, an FDA registered manufacturer, exceeds USP <797> standards and meets cGMP requirements. Committed to delivering the finest outsourcing services in the industry, Ameridose considers quality, exceptional customer service, and value to be central elements of its corporate mission.

###